MARKET

BCTX

BCTX

Briacell Therapeutics Corp
NASDAQ
3.690
-0.040
-1.07%
After Hours: 3.610 -0.081 -2.18% 17:35 11/10 EST
OPEN
3.730
PREV CLOSE
3.730
HIGH
3.820
LOW
3.600
VOLUME
25.16K
TURNOVER
--
52 WEEK HIGH
13.09
52 WEEK LOW
2.600
MARKET CAP
32.22M
P/E (TTM)
-0.5297
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BCTX last week (1102-1106)?
Weekly Report · 1d ago
Healthcare Stocks Advance: OBX Surges 38%, ONCO Gains 32%, TMDX Rises 26%
NASDAQ · 4d ago
BriaCell Reports Broad Preclinical Immunotherapy Activity at SITC
TipRanks · 4d ago
BriaCell and BriaPro Present Preclinical Immunotherapy Data
TipRanks · 11/03 16:14
Weekly Report: what happened at BCTX last week (1026-1030)?
Weekly Report · 11/02 09:06
Weekly Report: what happened at BCTX last week (1019-1023)?
Weekly Report · 10/26 09:06
BriaCell Highlights New Immune Biomarker Data in Metastatic Breast Cancer at ESMO 2026
TipRanks · 10/23 12:08
BriaCell presents clinical biomarker findings from MBC patients at ESMO
TipRanks · 10/23 11:51
More
About BCTX
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

Webull offers Briacell Therapeutics Corp stock information, including NASDAQ: BCTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTX stock methods without spending real money on the virtual paper trading platform.